Search results for: 'market analyst 2025'
- Did you mean
- market analyst 2014
- market analysi 2025
- Related search terms
- Markets & Markets, Synthetic Biology – Global forecast to 2027, 2023. 01
- 2025 china servic operations system industry market research report
- market analysi of rf energy harvesting technolog
- market+size+of+china's+overseas+marketing+industry
- market 08 00 00 00
-
27 May 2016  |  Africa  |  Market Research
Pharmaceutical Market Access Strategy for Ethiopia
Landscaping New Investment Opportunities Across the Pharmaceutical Value Chain
Scope of the report The research report includes the following segments: Product scope: Pharmaceutical Products Geographic scope: Ethiopia End-user scope: Pharmaceutical manufacturers, Pharmaceutical distributors, Healthcare providers, Contract Manufacturing Organisations (CMO) Revenue analysis and forecasts, drivers and restraints, business opp...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Nov 2017  |  North America  |  Market Research
Global Biologics Market—Companies-to-Action
Biopharma Companies are Increasingly Collaborating with CDMOs, CROs, and Digital and Medical Equipment Companies for Biologics Discovery and Development
This study on the "Global Biologics Market: Companies-to-Action" presents an overview of the global biologics landscape with an emphasis on the top 10 leading bio-pharma companies in the market. The study highlights the shifting focus and investments of bio-pharma companies towards biologics discovery and development, which is attributed to the gro...
$3,000.00
Special Price $2,250.00 save 25 %
-
27 Sep 2017  |  Africa  |  Market Research
East African Pharmaceutical Market, Forecast to 2021
Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers
Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities ...
$4,950.00
Special Price $3,712.50 save 25 %
-
07 Oct 2025  |  Global  |  Technology Research
Growth Opportunities in Radiopharmaceuticals
Emerging Interest from Big Pharma Players Is Pushing Industry Innovation Momentum
The report covers the clinical trial assessment for radiodiagnostics, including PET, SPECT, and radiopharmaceuticals, comprising Alpha therapy, Beta therapy, Auger Therapy, and Theranostics. The report covers the key players in each space and their contributions to the radiopharmaceuticals landscape.The report sheds light on technology innovations ...
$4,950.00 -
22 Sep 2025  |  Global  |  Technology Research
Growth Opportunities in Weight Management Technologies
Emerging Innovations Driving Personalized and Effective Obesity Solutions
This study focuses on emerging pharmacological and non-pharmacological strategies in the treatment of obesity, as well as evolving new paradigms for the future. It describes the contribution of incretin-based therapies, particularly GLP-1 receptor agonists and their multi-agonist counterparts, which provide robust effects on weight loss and metabol...
$4,950.00 -
24 Jun 2026  |  Global  |  Market Research
Top 5 Growth Opportunities in AI-Enabled Drug Discovery, 2026
Growing Precision Medicine Research is Driving Agile Partnerships with Newer OoC Technologies
As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.These disruptions continue to drive ...
$2,450.00 -
19 Sep 2018  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Feb 2026  |  Global  |  Technology Research
Growth Opportunities in Microbiome Technologies in Consumer Wellness, 2026–2030
Emerging Interest from Industry Players Is Boosting Growth in the Evolving Microbiome-Based Consumer Wellness Industry
The microbiome sector is a core component of the self-care movement, promoting proactive health behaviors. The gut microbiota is now recognized as an organ-like system that influences overall health and specific medical conditions, making continued advancement critical to enhancing well-being.The consumer wellness industry is evolving alongside gro...
$4,950.00 -
21 Aug 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...
$950.00 -
29 May 2024  |  Global  |  Technology Research
Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics)
Rising Popularity Among Tier 1 Pharma Companies and Technological Advances in Drug Delivery Push Biologics Development
There have been increasing incidences of rare ophthalmic diseases (e.g., retinitis pigmentosa, Stargardt disease, Leber congenital amaurosis) and prevalent diseases (e.g., age-related macular degeneration [AMD], geographic atrophy). While clinicians have used small molecules as the conventional therapeutic modality to manage these diseases, the urg...
$4,950.00
Special Price $3,712.50 save 25 %